{
    "2020-11-17": [
        [
            {
                "time": "2020-11-17",
                "original_text": "整合医疗资源、打通“药+险”链条 险企争入健康险新赛道",
                "features": {
                    "keywords": [
                        "医疗资源",
                        "药+险",
                        "健康险",
                        "新赛道"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "保险",
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2020-11-17",
                "original_text": "北上资金活跃股名单(11月17日)",
                "features": {
                    "keywords": [
                        "北上资金",
                        "活跃股",
                        "名单"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-18",
                "original_text": "A股头条之上市公司（11.18）",
                "features": {
                    "keywords": [
                        "A股",
                        "上市公司"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-11-17",
                "original_text": "水滴“好药付”首次披露数据 带病体保险能否突围？",
                "features": {
                    "keywords": [
                        "水滴",
                        "好药付",
                        "带病体保险"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "保险",
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2020-11-17",
                "original_text": "连续3日净买入恒瑞医药获沪股通净买入3亿元",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "沪股通",
                        "净买入"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-16",
                "original_text": "MLF超额续作提振情绪，陆股通加仓顺周期——金融市场流动性与监管动态周报（1116）",
                "features": {
                    "keywords": [
                        "MLF",
                        "陆股通",
                        "顺周期",
                        "流动性",
                        "监管动态"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-17",
                "original_text": "“烧钱王”百济神州要来A股上市了，它是如何10年亏掉200亿的？",
                "features": {
                    "keywords": [
                        "百济神州",
                        "A股",
                        "亏损"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2020-11-17",
                "original_text": "德展健康实际控制人将变更为新疆国资委、博敏电子及子公司拟超50亿元投资扩产",
                "features": {
                    "keywords": [
                        "德展健康",
                        "新疆国资委",
                        "博敏电子",
                        "投资扩产"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "电子"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2020-11-17",
                "original_text": "恒瑞医药：HR021611和HR091506片获批临床",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "HR021611",
                        "HR091506",
                        "临床试验"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2020-11-17",
                "original_text": "高瓴三季度持仓曝光：新进22家公司，10家为生物制药企业",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "生物制药",
                        "持仓"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}